Browse studies

Find your next paid study

4 recruiting studies matching your filters

Administration of Off-the-Shelf, Expanded, Most Closely HLA Matched, Third Party Adenovirus Specific T Cells for Therapy of Adenovirus Related Disease in Immunocompromised Patients

This phase I trial studies the side effects of allogeneic adenovirus-specific cytotoxic T lymphocytes (donor T cell therapy) and to see how well they work in t…

Hematopoietic and Lymphoid Cell NeoplasmImmunocompromised

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT03425526

Phase 2

Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely …

Viral InfectionViral ReactivationInfection in an Immunocompromised Host

Estimated

~$10 – $5,625

Children's Hospital Medical Center, CincinnatiNCT02532452

Observational

A Single Arm, Open Label Clinical Study to Assess the Safety and Efficacy of Intratumoral Alpha DaRT224 for the Treatment of Immunocompromised Patients With Cutaneous Squamous Cell Carcinoma

This is a multi-center clinical study enrolling up to 28 participants. The primary objectives are to determine the objective response rate (ORR) established by…

Squamous Cell CarcinomaAlpha RadiationImmunocompromised+3 more

Estimated

~$10 – $8,750

Alpha Tau Medical LTD.NCT06615635

Phase 3

A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with sever…

Lower Respiratory Tract InfectionParainfluenzaImmunocompromised+1 more

Estimated

~$10 – $8,750

Ansun Biopharma, Inc.NCT03808922